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Antibodies to double-stranded (dsDNA) are associated with
systemic lupus erythematosus (SLE) and directly involved in
human lupus nephritis. Information about their glomerular
target antigens is inconsistent, and whether availability of
target antigens, antibody specificity or avidity are
nephritogenic parameters, is not determined. In this study,
we analyzed renal tissue from anti-dsDNA antibody-positive
lupus patients with nephritis by morphological and
immunological assays, including immune electron
microscopy (IEM) and colocalization IEM, an EM-based
confocal microscopy assay. IEM demonstrated that antibody
deposits were confined to electron dense structures (EDS) in
glomerular membranes. These autoantibodies colocalized
with nucleosome-binding anti-dsDNA/-histone/-transcription
factor antibodies. To confirm the colocalization IEM-data, we
developed a colocalization terminal deoxynucleotidyl-
transferase (TdT) biotin-dUTP nicked end-labeled (TUNEL)
IEM assay where extracellular DNA was traced by TdT-
mediated introduction of biotinylated nucleotides and
autoantibodies by IEM. Results consistently demonstrated
that DNA colocalized with autoantibodies in glomerular
membrane-associated EDS. The colocalization IEM and
colocalization TUNEL IEM assays thus demonstrate that
intra-glomerular membrane-associated nucleosomes are
targeted by anti-dsDNA autoantibodies in human lupus
nephritis. The data provide a new approach to understand
basic molecular and immunological processes accounting for
antibody-mediated nephritis in human SLE.
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Systemic lupus erythematosus (SLE) is characterized by a
diversity of organ manifestations,1,2 of which lupus nephritis
is the most serious.3 There is a consensus internationally that
antibodies to double-stranded (dsDNA) represent a central
pathogenic factor in lupus nephritis,4–6 and anti-dsDNA
antibodies have been eluted from nephritic kidneys.7–9 There
is, however, no agreement as to which structures these
antibodies recognize in vivo in glomeruli, as anti-dsDNA
antibodies may crossreact with non-nucleosomal glomerular
constituents, such as mesangial cell membranes, laminin,
a-actinin, and others.8,10–16
Contemporary studies of antibody-mediated lupus ne-
phritis follow two main directions: (i) anti-dsDNA antibodies
form complexes with nucleosomes that deposit in glomer-
uli,4,17 or (ii) anti-dsDNA antibodies crossreact with non-
nucleosomal kidney antigen(s).10,11,13,16,18 Although there are
experimental data and theoretical considerations arguing for
and against both, conclusive data are still awaited that
definitively determine which glomerular structure(s) that are
targeted by murine nephritogenic antibodies in vivo. One
study by Kramers et al.19 may shed light on this problem as
they demonstrated that anti-nucleosome antibodies may
bind in glomeruli if they are complexed with nucleosomes,
whereas purified antibodies did not. This result clearly
supports a model where nephritogenic antibodies are bound
to nucleosomes trapped in glomeruli.17 However, if con-
clusive data still are awaited in nephritic mice, even less data
are available in human lupus nephritis.
Recently, we have described a new approach to study
target structures for anti-dsDNA antibodies in autoimmune
(NZBxNZW)F1 (BW) mice. By combining transmission
electron microscopy (TEM) and immune electron micro-
scopy (IEM) we demonstrated that in vivo-bound auto-
antibodies selectively associated with electron dense
structures (EDS) in glomerular capillary membranes as well
as in the mesangial matrix.9,20 As the antibodies did not bind
outside membrane-associated EDS, this indicated that
inherent membrane structures were not targeted by anti-
bodies in vivo.
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Subsequently, we demonstrated by colocalization IEM that
the in vivo-bound autoantibodies recognized the same
structures that were targeted by experimental monoclonal
antibodies to dsDNA, and oligoclonal antibodies to the
transcription factor TATA-binding protein (TBP), or to
histones.20 These data demonstrated that the glomerular
target structures for murine nephritogenic autoantibodies
were chromatin particles. These particles were most likely
released from intra-glomerular apoptotic cells that were
detected by the terminal deoxynucleotidyl-transferase (TdT)
biotin-dUTP nicked end-labeled (TUNEL) and caspase-3
assays in glomeruli characterized by presence of membrane-
associated EDS.20
To determine if similar glomerular changes are present in
human lupus nephritis, the colocalization IEM was extended
to implement colocalization of TUNEL-positive DNA with
glomerular deposited autoantibodies, denoted colocalization
TUNEL IEM assay. This assay yielded double staining of
DNA end-labeled by biotinylated nucleotides introduced by
TdT on one side, and of in situ-bound autoantibodies on the
other. In this respect, differential labeling of DNA contained
in EDS by an ultrastructural TUNEL assay and of in vivo-
bound autoantibodies phenomenologically confined to EDS
may control and complement the results of colocalization
IEM using experimental anti-chromatin antibodies. By
applying these assays to renal biopsies from human SLE
patients with nephritis, we specifically and precisely deter-
mined (i) that intra-glomerular, extracellular chromatin is
present in human lupus nephritis, (ii) the distinct localiza-
tion of extracellular chromatin in glomerular membranes,
and (iii) that end-labeled (TUNEL positive) chromatin fully
colocalize with glomerular in vivo-bound autoantibodies in
membrane-associated EDS.
RESULTS
ACR classification of the three human lupus nephritis
patients and WHO classification of their nephritis
Biopsies from three human lupus nephritis patients were
available as correctly prepared tissue for these studies. The
three patients fulfilled five (Patients 1 and 3), or six (Patient
2) of the ACR classification criteria for SLE.2 Information on
serum creatinine, autoantibodies, American College of
Rheumatology (ACR) classification of their SLE, proteinuria
and the WHO classification of the nephritic kidneys are
presented in Table 1. All three patients were positive for anti-
nuclear antibodies (ANA), whereas only Patients 2 and 3
produced Crithidia luciliae immunofluorescence test positive
anti-dsDNA antibodies. All had, however, anti-dsDNA
antibodies detected by enzyme-linked immunosorbent assay
at the time where the biopsies were taken (Figure 1a). Only
Table 1 | Classification of SLE and lupus nephritis by ACR and WHO classification criteria, respectively, serology and medication
of SLE Patients 1–3
WHO nephritis
SLE
patienta Age
Disease
duration (y) ACR criteriab Classification ANA titer CLIFT
s-Creatininec
lmol/l
Proteinuria
gram/day
Glomerular
Ig DIF Therapy
1 41 19 3, 7, 9–11 V 454 o10 56 2 IgG,A,M,C3 HC, CycA,
Pred
2 35 6 1, 6, 7, 9–11 IV 40 160 96 1,4 nrbd HC, MMF
3 34 o1 1, 6, 7, 10, 11 IV 454 160 97 8 IgG,A,M,C3 Pred
CycA, cyclosporin A; HC, hydrochloroquine, MMF, mycophenolatmofetil; Pred, prednisolon.
aAll three patients are female.
bThe ACR criteria are listed according to their numbers: 1. Malar rash, 2. Discioid rash, 3. Photosensitivity, 4. Oral ulcers, 5. Arthritis, 6. Serositis, 7. Renal disorder, 8. eurologic
disorder, 9. Hematologic disorder, 10. Immunologic disorders: nti-dsDNA, anti-Sm, and/or anti-phospholipid antibodies, 11. An abnormal titer of ANA (see reference Tan et al.2
for details).
cs-creatinine: serum creatinine, normal values 50–90 mmol/l.
dnrb: not representative biopsy because glomeruli were not present.
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Figure 1 | Autoantibody profiles determined in three human lupus nephritis patients. Sera were prepared from the patients at the time
the kidney biopsies were sampled. Twofold serum dilution analyses were performed using (a) calf thymus dsDNA or (b) murine nucleosomes as
target antigens in enzyme-linked immunosorbent assay. (c) Dilution curves for the positive control monoclonal antibody 163p77 against
dsDNA and nucleosomes are demonstrated. Broken lines in (a–c) indicate cutoff values.
Kidney International (2007) 71, 664–672 665
M Kalaaji et al.: Nucleosomes in human lupus nephritis o r i g i n a l a r t i c l e
Patient 3 produced antibodies binding eukaryotic nucleo-
somes above cutoff (Figure 1b). Figure 1c demonstrates
binding of the murine antibody 163p77 to dsDNA and
nucleosomes which is included as intra-assay control to
validate results presented in Figure 1a and b.
Morphological characterization of glomeruli of human kidney
biopsies
Light microscopy analysis of glomeruli in kidney of Patient 1
demonstrated membranous nephritis (WHO V, Figure 2a for
hematoxylin and eosin-stained glomerulus) with thickened
capillary membranes and membrane-associated EDS (Figure
3a). By direct immunofluorescence assay (DIF), granular
deposits of immunoglobulin (Ig)G are demonstrated in
capillary membranes, but also in the mesangial matrix
(Figure 2b, enlarged in Figure 2c). Glomeruli from Patient
2 demonstrated diffuse, proliferative nephritis (WHO class
IV, Figure 2d), and presence of chromatin fragments (see
arrows in Figure 2e, representing an enlarged section of
Figure 2d). Presence of membrane-associated EDS in
glomeruli from this patient is confirmed by TEM and IEM
analyses (see below for colocalization TUNEL IEM assay for
all three patients). DIF was not performed, as the biopsy
from Patient 2, prepared for this analyses, did not contain
glomeruli, whereas biopsies prepared for the different
electron microscopy analyses were representative and yielded
interpretable results (see below). Glomeruli from Patient 3
were characterized by mesangial proliferation (WHO IV)
(Figure 2f), and glomerular membrane-associated EDS both
in the mesangial matrix and the capillary membranes (Figure
4a). DIF revealed granular deposits of IgG in glomerular
mesangium and capillary membranes (Figure 2g, enlarged in
Figure 2h). Glomeruli from healthy kidneys did not contain
membrane associated EDS, and were therefore not included
in the following analyses (data not shown, see also21).
TEM, IEM, and colocalization IEM analyses of glomeruli
of lupus Patients 1–3
TEM of Patient 1 glomeruli (WHO V) demonstrated EDS
associated with capillary and mesangial matrix membranes
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Figure 2 | Characterization of glomeruli of human kidney biopsies by light and direct immunofluorescence microscopy. (a, d enlarged in
e, f) Glomeruli in kidneys of Patients 1–3 are characterized by light microscopy of sections stained by hematoxylin and eosin for glomeruli of
Patients 1, 2, and 3, respectively. DIF analysis of glomeruli was performed on biopsies from Patients 1 (b, enlarged in c) and Patient 3,
(g, enlarged in h). DIF analysis was not performed on the biopsy from Patient 2, as this biopsy was not representative for this analysis.
(e) Arrows point at examples of chromatin subparticles.
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(Figure 3a), and partially confluent podocytes. IEM analysis
established that IgG autoantibodies (traced by 5 nm gold
particles) were exclusively bound in the areas constituted by
EDS (Figure 3b).
In order to generate information on the nature of the
membrane-associated EDS in glomeruli of Patient 1,
colocalization IEM was performed. The results demonstrated
that the autoantibodies and the experimental 163p77 anti-
dsDNA (Figure 3c), the anti-histone H3 (Figure 3d) or anti-
TBP (Figure 3e) antibodies colocalized exclusively in the
EDS, and none of the antibodies bound regular GBM or
mesangial matrix structures. Control experiments, as those
presented in Figure 3f and g using rabbit anti-mouse (RaM)
IgG instead of rabbit anti-human IgG antibodies in Step 1
(IEM, Figure 3f)), anti-lactoferrin (data not shown), or anti-
desmin antibodies (Figure 3g) followed by RaM IgG
antibodies and protein A conjugated with 10 nm gold
particles (PAG-10 nm) in Step 2, resulted in negligible
binding of gold particles in the sections. This demonstrates
that the results presented in panels of Figure 3c and e on
colocalization IEM are valid.
Biopsies from Patients 2 and 3 were characterized by
accumulation of EDS both in capillary membranes and in the
mesangial matrix, as demonstrated by TEM (Figure 4a for
biopsy from Patient 3). Autoantibody deposits were confined
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Figure 3 | Transmission, immune, and colocalization IEM of
glomeruli of SLE Patient 1. (a) TEM analysis demonstrates EDS
(arrows) in both mesangial matrix and capillary membranes. IEM
identify autoantibody deposits, traced by 5 nm gold, strictly located
in (b) EDS. Colocalization IEM demonstrate that (c) anti-dsDNA
163p77, (d) anti-histone H3, or (e) anti-TBP antibodies (all traced by
10 nm gold) colocalize with glomerular in vivo-bound autoantibodies
(5 nm gold). No binding of any of the antibodies to regular GBM
could be detected. In (f and g) control experiments are presented to
validate the colocalization IEM. In (f), Step 1 (the standard IEM) was
performed with RaM IgG antibodies followed by PAG-5 nm. The latter
reagents did not bind demonstrating that RaM IgG antibodies did not
crossreact with deposited human IgG. In (g), the sections were
incubated with the irrelevant mouse anti-desmin IgG control
antibody instead of antibodies reactive with nucleosomes before
adding RaM IgG antibodies and PAG-5 nm. The almost complete
absence of gold particles in (f and g) demonstrates that the results
in (c–e) are valid.
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Figure 4 | Transmission, immune, and colocalization IEM of
glomeruli of SLE Patient 3. TEM and IEM analyses revealed heavy
mesangial and capillary membrane-associated EDS (a, arrows point at
EDS in mesangium), and autoantibody deposits were strictly confined
to EDS (b). Colocalization IEM analyses revealed that both (c)
anti-dsDNA 163p77, (d) anti-histone H3, and (e) anti-TBP antibodies
(10 nm gold) recognized EDS and colocalized with the in vivo-bound
autoantibodies (5 nm gold).
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to EDS in mesangium and capillary membranes (Figure 4b).
Colocalization IEM using anti-dsDNA, anti-histone H3, or
anti-TBP antibodies, demonstrated that the experimental
antibodies recognized the same structures that are targeted by
in vivo-bound autoantibodies (Figure 4c, d, and e, for anti-
dsDNA, anti-H3, and anti-TBP antibodies, respectively). The
data presented in Figure 4 for biopsy 3 are fully representative
for those obtained in biopsy 2.
Colocalization TUNEL IEM to determine glomerular loci for
deposits of autoantibodies and of potentially apoptotic
extracellular chromatin
Results of this colocalization TUNEL IEM assay applied to
DNase 1 digested glomeruli of Patient 1 is demonstrated in
Figure 5. DNase 1-induced nicked DNA (traced by 10 nm
gold) was detected in EDS, as well as in nuclear chromatin,
whereas autoantibodies (traced by 5 nm gold) were mostly
confined to EDS in the glomerular membranes (Figure 5a,
enlarged in Figure 5b for EDS, and labeled nucleus in Figure
5c). In Figure 5a, it is also demonstrated that material within
the capillary lumen contains structures that are TUNEL
positive, and to which antibodies have bound in vivo. Thus,
end-labeled DNA and the autoantibodies colocalized solely in
EDS in mesangial matrix, capillary lumen and membranes.
Colocalization TUNEL IEM assay was not performed on
DNase 1 non-digested sections for this patient, while
performed on the next 2 kidney biopsies.
The colocalization TUNEL IEM assay was performed on
glomeruli of Patient 2 without preceding DNase 1 digestion.
The glomeruli were characterized by confluent podocyte (not
shown) and by accumulation of EDS in mesangial matrix and
capillary membranes (Figure 6a). Confined to these EDS,
autoantibodies (5 nm gold particles), and nicked end-labeled
DNA (10 nm gold particles) are stained, whereas the
a
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Figure 5 | Ultrastructural detection of glomerular loci for deposits
of autoantibodies and extracellular chromatin by colocalization
TUNEL IEM assay in Patient 1. In (a), glomerular sections were
digested by DNase 1, followed by TdT-mediated introduction of
biotinylated nucleotides to nicked DNA ends. Biotinylated
nucleotides were traced by anti-biotin antibodies and PAG-10 nm,
whereas on the same sections autoantibodies were traced by
PAG-5 nm gold particles. Colocalization of nicked end-labeled DNA
and autoantibodies was confined to membrane-associated EDS
(a, enlarged in b). No extracellular DNA could be traced outside the
EDS within the membranes, whereas double-stained material is
visible in the capillary lumen. In nuclei, 10 nm gold particles are
detected, whereas nuclear binding of autoantbodies in vivo could not
be detected (a, enlarged in c).
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Figure 6 | Ultrastructural detection of glomerular loci for deposits
of autoantibodies and extracellular chromatin by colocalization
TUNEL IEM assay in Patient 2. In (a), autoantibodies (traced by
5 nm gold) and nicked end-labeled DNA (traced by 10 nm gold)
colocalized in membrane-associated EDS (a, enlarged in b). As a
negative control, the colocalization TUNEL IEM assay was performed
with exclusion of TdT. As is demonstrated in (c, enlarged in d),
autoantibodies are still detected in EDS, whereas anti-biotin
antibodies and PAG-10 nm gold conjugate, tracing nicked end-
labeled DNA, did not bind nonspecifically to the sections. As a
positive control, the sections were digested with DNase 1 before
colocalization TUNEL IEM assay. (e, enlarged in f), Demonstrates
mixed pattern of autoantibody (5 nm gold) and nicked end-labeled
DNA (10 nm gold) in EDS of the glomerular membranes. (a and b)
This pattern is highly similar to the pattern seen in the assay on
sections not pretreated with DNase 1.
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membrane structures surrounding the EDS are negative for
both parameters (Figure 6a, enlarged in Figure 6b). This assay
demonstrated therefore presence of in vivo, glomerular
membrane associated TUNEL-positive structures, indicating
accumulation of apoptotic nucleosomes in these kidneys. To
control specificity and validity of the TUNEL IEM assay
applied to extracellular chromatin, exactly the same assay,
however with the exclusion of TdT, was performed, which
resulted in nearby exclusive detection of 5 nm gold-stained
autoantibodies in the EDS (Figure 6c, enlarged in Figure 6d).
If the colocalization TUNEL IEM assay was preceded by
DNase 1-digestion of the tissue section, the nicked end-
labeled DNA still fully colocalized with autoantibody deposits
in EDS (5 and 10 nm gold particles for autoantibodies and
end-labeled DNA, respectively, in Figure 6e, enlarged in
Figure 6f).
The same experimental protocol was applied to glomeruli
of Patient 3. The colocalization TUNEL IEM assay revealed
that end-labeled DNA (10 nm gold) and autoantibodies
(5 nm gold) perfectly colocalized in EDS (Figure 7a). This
double staining was specific, as the colocalization TUNEL
IEM assay performed without including the enzyme TdT
resulted in complete loss of 10 nm gold particles (which
would reflect end-labeled DNA) both in nuclei (Figure 7b), as
well as in EDS, whereas autoantibodies still are detected in
EDS as 5 nm gold particles (Figure 7b and c, the latter
enlarged in Figure 7d and e). In contrast, running the
colocalization TUNEL IEM assay on a DNase 1 digested
glomerular section resulted in strong staining of nicked DNA
(10 nm gold) and autoantibodies (5 nm gold) in EDS and not
in membranes surrounding the EDS (Figure 7f, enlarged in
Figure 7g).
These results are consistent with presence of nicked DNA
in membrane-associated EDS in glomeruli of human
nephritic kidneys, and introduction of additional nicks by
DNase 1 digestion did not uncover further DNA within the
glomerular membranes.
DISCUSSION
Although studied over several decades, the etiology and
pathophysiology of lupus nephritis still remain difficult to
understand. During recent years, the processes accounting for
lupus nephritis has been studied with a particular focus on
the biological role and molecular specificity of glomerular in
vivo-binding autoantibodies. Irrespective which role such
autoantibodies constitute, whether able to initiate and
maintain, or just maintain, nephritis, their glomerular target
structures need to be determined.
This study was performed to determine the nature and
distinct localization of glomerular target structures for in
vivo-bound nephritogenic autoantibodies in established hu-
man lupus nephritis. Recently, we have demonstrated that
chromatin particles released from intra-glomerular dead cells
may re-distribute to the mesangial matrix and capillary
membranes in nephritis of BW mice.20
In the same study, it appeared that the glomerular loci for
autoantibody-binding in vivo were confined to EDS,9,20 as
determined by TEM and IEM. To describe the nature of such
EDS, we used an adaptation of double immunolabeling
assays,22 denoted colocalization IEM to allow individual
staining of autoantibody deposits and of in situ-bound
experimental antibodies to dsDNA, histones and transcrip-
tion factors, or to intrinsic glomerular membrane structures
like collagen IV or laminin, added to the same sections.20 The
data were consistent and demonstrated that glomerular
basement membrane-associated nucleosomes were present
in EDS, and acted as in vivo target structures for
nephritogenic autoantibodies. No autoantibody-binding
pattern was consistent with specificity for intrinsic glomer-
ular membrane-related structures.
The results obtained in nephritic BW kidneys may not be
fully relevant to human lupus nephritis. Compared to the
murine lupus nephritis, the human variant is a more
a
b c d
e
f g
Figure 7 | Ultrastructural detection of glomerular loci for deposits
of autoantibodies and extracellular chromatin by colocalization
TUNEL IEM assay in Patient 3. (a) Colocalization TUNEL IEM assay
demonstrates that autoantibodies (5 nm gold) and nicked end-
labeled DNA (10 nm gold) colocalized in membrane-associated EDS.
The same assay in absence of TdT resulted in detection of
autoantibodies in (b–e) EDS, whereas (b–e) 10 nm gold was virtually
absent, notably also in (b) the nucleus. Pretreating the sections with
DNase 1 before colocalization TUNEL IEM yielded double staining of
the EDS (f, enlarged in g) similar to results of the assay performed
without (a) DNase 1 pretreatment.
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polymorphic disease.3,23 Also, results from colocalization
IEM depended solely on the relative specificity of the
experimental anti-chromatin antibodies. This was an issue
we had to consider as anti-chromatin autoantibodies may
bind chemically unrelated structures,12,13,15,16,24,25 which may
make results of this assay questionable, if not controlled by an
independent, precise assay. In order to progress into analyses
of target structures for nephritogenic autoantibodies in
human lupus nephritis, it was therefore imperative to
develop an alternative DNA-specific assay to confirm that
the target structures for nephritic, in vivo-bound autoanti-
bodies indeed represent dsDNA in form of nucleosomes or
chromatin subparticles.
We therefore applied the DNA-specific TUNEL assay to
IEM on human glomerular sections. If EDS in glomerular
membranes represent nucleosomes that derive from apopto-
tic cells, they should be directly TUNEL assay positive. If
undetectable, DNase 1-induced nicked ends could be labeled
and traced by the TUNEL assay. This would still represent a
highly DNA-specific assay, independent from the immune
staining of structures by colocalization IEM. One important
advantage of this protocol is that it may be combined with an
intra-assay detection of autoantibody deposits. This pre-
cludes the use of in situ hybridization assay to analyse for
colocalization of membrane-associated DNA and autoanti-
bodies, as this assay includes a dissociation step that also will
dissociate in situ-bound antibodies.
The results of the colocalization TUNEL IEM assay
demonstrates that TUNEL-positive DNA and autoantibody
deposits are dominantly located in the same membrane-
associated electron dense areas, whereas minor deposits were
present in the membranes outside the EDS. Whether such
less pronounced deposits were constituted by small-sized
nucleosomes that may be difficult to detect as EDS is
uncertain. Most interestingly, TUNEL- and antibody-positive
structures are occasionally detected in capillary lumens (see
e.g. data in Figure 5a). This may indicate that apoptotic
chromatin may reach glomeruli through the circulation, or
that they derive from, for example, apoptotic endothelial cells
(experiments in progress). Nevertheless, data obtained by the
colocalization TUNEL IEM extend results of colocalization
IEM assays from murine20 to human lupus nephritis. Based
on results of the two independent colocalization assays, we
conclude that de facto target structures for glomerular in
vivo-bound autoantibodies are chromatin subparticles, and
not obligate glomerular membrane structures. As these
results are controlled by independent high-resolution assays,
they give important clues to improve our understanding of
human lupus nephritis. Whether EDS in other glomerular
disorders (see e.g. data by Nakajima et al.26) are composed of
chromatin subparticles, is currently under investigation in
our laboratory.
Whether nucleosomes associate with mesangial matrix
and capillary membranes through affinity owing to electro-
static or other forces, or are trapped in the membranes like
fish in net, has not been determined. Izui et al.27 demon-
strated in 1976 that collagen and collagen-like material in
glomerular basement membranes had a particularly high
affinity for any DNA tested (mammalian, bacterial, viral, and
plant DNA). However, as DNA in vivo is present in the
nucleosomal form that may have other binding properties
than isolated DNA, the observations of Izui et al.27 may not
be relevant for an in vivo situation in mammalians. Berden
et al. have addressed this question by analysing if nucleo-
somes had affinity to glomerular membranes. They found by
perfusing kidneys with nucleosome-anti-DNA antibody
complexes, binding of the complexes in glomeruli (reviewed
by Dieker et al.4 and Berden et al.28,29). This binding process
may relate to the ability of chromatin or its components to
bind to the GBM. The interaction has been claimed to be
mediated by binding of exposed nucleosomal histone N- and/
or C-terminal ends with collagen IV, heparan sulfate, or with
other negatively charged residues in the glomeruli (reviewed
by Berden et al.28 and Lefkowith and Gilkeson30). In their
studies, Grootscholten et al.31 and van Bruggen et al.32 have
observed nucleosomal antigens (histones and DNA) in the
epidermal basement membranes in skin and in glomeruli in
biopsies from SLE patients. This may indicate a similar
mechanism for skin and kidney affections in SLE. In context
of these models, they discussed if the origin of extracellular
chromatin would be apoptotic cells.4,17,29
This is an attractive model that can explain why
individuals may have high levels of anti-dsDNA antibodies
without having nephritis, whereas other anti-dsDNA anti-
body positive patients may have nephritis (discussed by
Shlomchik and Madaio6). The reason for this may not be that
nephritic lupus patients produce particular ‘nephritogenic’
anti-dsDNA antibody subpopulations, but rather that avail-
ability of extracellular chromatin, released from, for example,
apoptotic glomerular cells, is a prerequisite for the antibodies
to bind in the glomeruli, and thereby to be involved in
nephritic processes.
The low levels of antibodies to nucleosomes in the present
study may be consistent with this assumption. As the level of
anti-dsDNA antibodies are relative high, whereas those of
anti-nucleosome antibodies are low, this may indicate that
the latter antibody population is adsorbed to membrane-
associated EDS, as recently described in BW mice.20
MATERIALS AND METHODS
Human kidney biopsies and paired serum samples
Kidney biopsies from three female SLE patients with nephritis were
collected, prepared, and stored as described previously,9,33 and
paired serum samples were frozen at 201C until use. The biopsies
were taken owing to exacerbation (Patient 1) or first onset of lupus
nephritis (Patients 2 and 3). The study was approved by the Regional
Ethical Committees in Lund, Sweden, and in Northern Norway.
Antigens and antibodies
Nucleosomes were generated from chromatin of murine spleen cells
as described.34 Calf thymus dsDNA was obtained from Sigma
(St Louis, USA) and S1 nuclease digested before use.35
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The following antibodies were used in this study: oligoclonal
antibodies against TBP and histone H3 (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), fluorescein isothiocyanate-conjugated rabbit
anti-human IgG (Sigma), and fluorescein isothiocyanate-conjugated
rabbit anti-human IgA/IgM/C3 (DAKO, Copenhagen, Denmark)
antibodies. The murine anti-dsDNA monoclonal antibody 163p77 was
obtained from Dr T Marion (University of Tennessee Health Science
Center, Memphis). Antibodies used in IEM analyses are described below.
Detection of serum antibodies
Antibodies in sera from the human SLE patients against calf thymus
dsDNA and nucleosomes were detected by standard indirect
enzyme-linked immunosorbent assay, as described in detail.9,33
The murine monoclonal antibody 163p77, reactive with dsDNA and
nucleosomes, were run intra-assay for validation of the enzyme-
linked immunosorbent assay results.9,36 Detection and titration of
anti-dsDNA antibodies by Crithidia luciliae immunofluorescence
test was performed as originally described by Aarden et al.37
Light and direct immunofluorescence microscopy
Histopathology assessment was performed on 4 mm sections of
paraffin-embedded, formalin fixed kidneys stained with hematox-
ylin and eosin. Glomerular deposits of IgG, IgA, IgM, and C3 were
detected by standard DIF on cryosections (4mm) of human kidneys
using anti-human IgG, IgA, IgM, and C3-specific fluorescein
isothiocyanate-conjugated antibodies.
TEM, IEM, and colocalization IEM
TEM was performed to characterize morphological changes in
human lupus nephritic kidney biopsies, as described.20,33
For IEM, ultrathin cryosections of kidney biopsies were
processed as described,20,33 with modifications related to the use
of human instead of murine kidney specimens as follows. Detection
of glomerular in vivo-bound autoantibodies were performed by
incubating the sections with rabbit anti-human IgG antibodies (RaH
IgG, Monosan, Uden, The Netherlands), followed by protein A
conjugated with 5 nm gold particles (PAG-5 nm) (University of
Utrecht, The Netherlands). This procedure is also Step 1 in the
colocalization IEM.
The colocalization IEM has recently been published in detail.20
Shortly, Step 1 (IEM, see above) was carried out to trace glomerular
in vivo-bound autoantibodies, followed by blocking the sections
with glutaraldehyde and saturation of free aldehyde groups with
glycine. Subsequently, the sections were incubated with experi-
mental murine antibodies directed against the chromatin compo-
nents dsDNA, histone H3, or TBP (Step 2). The sections were
subsequently incubated with RaM IgG followed by PAG-10 nm to
visualize presence of the experimental antibodies added in Step 2. By
this approach, the structures recognized by the autoantibodies could
be determined by their eventual colocalization with the added
experimental structure-specific antibodies. Specificity and validity of
double labeling of autoantibodies and experimental antibodies for
colocalization was verified using control IgG antibodies to desmin
and lactoferrin (both obtained from Sigma), or phosphate-buffered
saline instead of antibodies to dsDNA/H3/TBP, and rabbit-anti-
mouse IgG antibodies instead of rabbit anti-human IgG antibodies
in IEM to control that RaM IgG antibodies did not crossreact with
human IgG (see Figure 3 for details).
Micrographs were taken at  50–70k total magnification using a
Jeol JEM-1010 Transmission Electron Microscope (Tokyo, Japan).
Ultrastructural detection of glomerular extracellular
chromatin by in situ TUNEL assay in combination with
IEM (colocalization TUNEL IEM)
Extracellular chromatin was detected by the in situ nicked end-
labeling assay applied to electron microscopy, according to standard
protocols,38,39 with minor modifications. Ultrathin cryosections
were equilibrated in TdT reaction buffer (25 mM Tris-HCl, 200 mM
potassium cacodylate, 1 mM CoCl2, 25 mg/ml bovine serum albumin,
pH 6.6) for 5 min, and then incubated with 400 U recombinant TdT
(Roche Applied Science, Penzberg, Germany) in TdT reaction buffer
supplemented with 40 mM Biotin 16-dUTP, for 60 min at 371C in a
humid chamber (Hybrite, Vysis, Abbot Molecular Inc., Des Plaines,
IL, USA). Before labeling with TdT, positive control sections were
incubated with 3 U/ml DNase 1 in 40 mM Tris-HCl, 6 mM MgCl2, pH
7.5, for 10 min at room temperature. The reaction was terminated
with 10 mM Tris-HCl, 1 mM ethylenediaminetetraacetic acid. Nega-
tive control sections were assayed in the same buffer, however
excluding TdT. The grids were rinsed in termination buffer for
15 min at room temperature, washed with ddH2O followed by
phosphate-buffered saline, and incubated with 1% fish skin gelatin.
The grids were then incubated with rabbit anti-human IgG
antibodies for 20 min at room temperature followed by incubation
with PAG-5 nm to detect and locate in vivo-bound glomerular
autoantibodies. Subsequently, the grids were blocked for 5 min with
1% glutaraldehyde, followed by 0.12% glycine. At this stage
incorporated biotinylated nucleotides were detected by incubating
the sections with rabbit anti-biotin antibody ((Roche) diluted 1:500
in fish skin gelatin) for 20 min before incubation with PAG-10 nm
(diluted 1:60 in fish skin gelatin). The grids were washed with
phosphate-buffered saline for 10 min between all incubations.
Finally, the grids were contrasted with 3% uranyl acetate in methyl
cellulose for 6 min, air dried, and examined using the Jeol JEM-1010
Transmission Electron Microscope.
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